Women in the intervention group reported fewer prolapse symptoms ( ie , a significantly greater reduction in the pelvic organ prolapse symptom score [ POP-SS ] ) at 12 months than those in the control group ( mean reduction in POP-SS from baseline 3.77 [ SD 5.62 ] vs 2.09 [ 5.39 ] ; adjusted difference 1.52 , 95 % CI 0.46-2 .59 ; p = 0.0053 ) .